HRVIX | SSGSX | HRVIX / SSGSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 31 years | 26 years | - |
Gain YTD | 6.213 | 2.915 | 213% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 298M | 6.85B | 4% |
Annual Yield % from dividends | 0.87 | 0.35 | 244% |
Returns for 1 year | 7.08 | 4.35 | 163% |
Returns for 3 years | -15.91 | -0.70 | 2,284% |
Returns for 5 years | 13.41 | 9.53 | 141% |
Returns for 10 years | 20.65 | 18.43 | 112% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PYVAX | 19.30 | N/A | N/A |
Payden Equity Income Adviser | |||
DUSLX | 39.27 | -0.15 | -0.38% |
DFA US Large Cap Growth Instl | |||
RIRGX | 72.76 | -0.37 | -0.51% |
American Funds Capital Income Bldr R6 | |||
VALLX | 39.77 | -0.29 | -0.72% |
Value Line Larger Companies Focused Inv | |||
APGRX | 20.57 | -0.18 | -0.87% |
Yorktown Growth Institutional |